SMT201600479B - Nuove soluzioni terapeutiche per il trattamento di condizioni neuroinfiammatorie - Google Patents
Nuove soluzioni terapeutiche per il trattamento di condizioni neuroinfiammatorieInfo
- Publication number
- SMT201600479B SMT201600479B SM201600479T SM201600479T SMT201600479B SM T201600479 B SMT201600479 B SM T201600479B SM 201600479 T SM201600479 T SM 201600479T SM 201600479 T SM201600479 T SM 201600479T SM T201600479 B SMT201600479 B SM T201600479B
- Authority
- SM
- San Marino
- Prior art keywords
- treatment
- inflammatory conditions
- new therapeutic
- therapeutic solutions
- neuro inflammatory
- Prior art date
Links
- 230000002314 neuroinflammatory effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09305265A EP2236158A1 (en) | 2009-03-30 | 2009-03-30 | New therapeutic approaches for treating neuroinflammatory conditions |
| EP10711227.8A EP2413970B1 (en) | 2009-03-30 | 2010-03-29 | New therapeutic approaches for treating neuroinflammatory conditions |
| EP14156048.2A EP2735316B1 (en) | 2009-03-30 | 2010-03-29 | New therapeutic approaches for treating neuroinflammatory conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201600479B true SMT201600479B (it) | 2017-03-08 |
Family
ID=41463183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201600479T SMT201600479B (it) | 2009-03-30 | 2016-12-30 | Nuove soluzioni terapeutiche per il trattamento di condizioni neuroinfiammatorie |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8642566B2 (it) |
| EP (3) | EP2236158A1 (it) |
| CY (1) | CY1118455T1 (it) |
| DK (1) | DK2735316T3 (it) |
| ES (2) | ES2609962T3 (it) |
| HR (1) | HRP20161794T1 (it) |
| HU (1) | HUE032356T2 (it) |
| LT (1) | LT2735316T (it) |
| PL (1) | PL2735316T3 (it) |
| PT (1) | PT2735316T (it) |
| SI (1) | SI2735316T1 (it) |
| SM (1) | SMT201600479B (it) |
| WO (1) | WO2010115741A2 (it) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2535046A1 (en) * | 2011-06-17 | 2012-12-19 | Institut Pasteur | Use of mecamylamine in the treatment of pathogen-infected patients with central nervous system disorder |
| WO2015051152A1 (en) * | 2013-10-03 | 2015-04-09 | Leuvas Therapeutics | Modulation of leukocyte activity in treatment of neuroinflammatory degenerative disease |
| KR101809379B1 (ko) | 2016-10-13 | 2017-12-14 | 연세대학교 산학협력단 | 디오스민 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용 조성물 |
| WO2020212553A1 (en) * | 2019-04-18 | 2020-10-22 | Université de Liège | New pyrimidine derivatives for prevention and treatment of gram-negative bacterial infection, contamination and fouling |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8569277B2 (en) * | 2004-08-11 | 2013-10-29 | Palo Alto Investors | Methods of treating a subject for a condition |
-
2009
- 2009-03-30 EP EP09305265A patent/EP2236158A1/en not_active Withdrawn
-
2010
- 2010-03-29 PT PT141560482T patent/PT2735316T/pt unknown
- 2010-03-29 LT LTEP14156048.2T patent/LT2735316T/lt unknown
- 2010-03-29 EP EP10711227.8A patent/EP2413970B1/en not_active Not-in-force
- 2010-03-29 ES ES14156048.2T patent/ES2609962T3/es active Active
- 2010-03-29 SI SI201031363A patent/SI2735316T1/sl unknown
- 2010-03-29 PL PL14156048T patent/PL2735316T3/pl unknown
- 2010-03-29 EP EP14156048.2A patent/EP2735316B1/en active Active
- 2010-03-29 HU HUE14156048A patent/HUE032356T2/en unknown
- 2010-03-29 ES ES10711227T patent/ES2530847T3/es active Active
- 2010-03-29 DK DK14156048.2T patent/DK2735316T3/en active
- 2010-03-29 US US13/260,773 patent/US8642566B2/en not_active Expired - Fee Related
- 2010-03-29 WO PCT/EP2010/054068 patent/WO2010115741A2/en active Application Filing
-
2016
- 2016-12-28 HR HRP20161794TT patent/HRP20161794T1/hr unknown
- 2016-12-30 SM SM201600479T patent/SMT201600479B/it unknown
-
2017
- 2017-01-03 CY CY20171100003T patent/CY1118455T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE032356T2 (en) | 2017-09-28 |
| US20120108528A1 (en) | 2012-05-03 |
| LT2735316T (lt) | 2017-04-10 |
| ES2609962T3 (es) | 2017-04-25 |
| PL2735316T3 (pl) | 2017-06-30 |
| PT2735316T (pt) | 2017-01-10 |
| WO2010115741A2 (en) | 2010-10-14 |
| DK2735316T3 (en) | 2017-01-23 |
| EP2413970B1 (en) | 2015-01-07 |
| ES2530847T3 (es) | 2015-03-06 |
| EP2735316A1 (en) | 2014-05-28 |
| EP2735316B1 (en) | 2016-10-05 |
| US8642566B2 (en) | 2014-02-04 |
| HRP20161794T1 (hr) | 2017-03-10 |
| CY1118455T1 (el) | 2017-07-12 |
| WO2010115741A3 (en) | 2010-12-02 |
| SI2735316T1 (sl) | 2017-05-31 |
| EP2236158A1 (en) | 2010-10-06 |
| EP2413970A2 (en) | 2012-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMAP200900085A (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative | |
| IL200368A0 (en) | Treatment of diseases characterized by inflammation | |
| SMT201400160B (it) | Nuove composizioni per il trattamento di cmt e malattie correlate | |
| ZA201107449B (en) | Compounds for the treatment of metabolic disorders | |
| IT1402865B1 (it) | Procedimento per il trattamento di acqua contaminata | |
| ZA201107446B (en) | Compounds for the treatment of metabolic disorders | |
| EP2566520A4 (en) | METHOD FOR TREATING IL1-MEDIATED INTERFERENCE | |
| ZA201107445B (en) | Compound for the treatment of metabolic disorders | |
| SMT201600479B (it) | Nuove soluzioni terapeutiche per il trattamento di condizioni neuroinfiammatorie | |
| BRPI1007543A2 (pt) | tratamento de psoríase | |
| GB201202095D0 (en) | Topical medicament for the treatment of psoriasis | |
| ZA201305970B (en) | Arylosulfonami for the treatment of cns diseases | |
| ZA200905364B (en) | Treatment of diseases characterized by inflammation | |
| IT1403587B1 (it) | Composizione per il trattamento di disordini metabolici | |
| EP2416803A4 (en) | NEW METHODS OF TREATING INFLAMMATORY DISEASES | |
| HK1158954A1 (en) | 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases | |
| GB201012926D0 (en) | Compounds for treatment of inflammation | |
| GB201006167D0 (en) | Compounds for the treatment of metabolic disorders | |
| IL223385B (en) | Treatment of inflammatory disorders | |
| GB201006166D0 (en) | Compounds for the treatment of metabolic disorders | |
| EP2701702A4 (en) | OXYMETAZOLINE FOR THE TREATMENT OF ANO-RECTAL DISEASES | |
| IT1398032B1 (it) | Transferrina per il trattamento di malattie autoimmuni. | |
| IT1406405B1 (it) | Molecole peptidiche per il trattamento di patologie mitocondriali | |
| GB0819446D0 (en) | Treatment of inflammatory disorders | |
| IT1399791B1 (it) | Composizioni farmaceutiche per il trattamento della poliposi nasale |